stimolare nuovo anno attraente pi rads 3 forum 945 ozono colpetto
MRI Based Radiomics Compared With the PI-RADS V2.1 in the Prediction of Clinically Significant Prostate Cancer: Biparametric vs Multiparametric MRI. - Abstract - Europe PMC
Single center analysis of an advisable control interval for follow-up of patients with PI-RADS category 3 in multiparametric MRI of the prostate | Scientific Reports
Prostate cancer upgrade, downgrade rates in P | EurekAlert!
Combination of PI-RADS score and PSAD can improve the diagnostic accuracy of prostate cancer and reduce unnecessary prostate biopsies. - Abstract - Europe PMC
JPM | Free Full-Text | Equivocal PI-RADS Three Lesions on Prostate Magnetic Resonance Imaging: Risk Stratification Strategies to Avoid MRI-Targeted Biopsies
Guidelines for PI-RADS 2.1 for management of PI-RADS 3 lesions in the... | Download Scientific Diagram
JCM | Free Full-Text | Radiomics in PI-RADS 3 Multiparametric MRI for Prostate Cancer Identification: Literature Models Re-Implementation and Proposal of a Clinical–Radiological Model
PI-RADS 3 lesions: Does the association of the lesion volume with the prostate-specific antigen density matter in the diagnosis of clinically significant prostate cancer? - ScienceDirect
Active Surveillance Strategies for Low-Grade Prostate Cancer: Comparative Benefits and Cost-effectiveness | Radiology
Il PI-RADS in risonanza magnetica prostatica: cosa indica?
Clinically Significant Prostate Cancer Detection in bpMRI using models trained with Report Guided Annotations - Grand Challenge
Frontiers | Transverse prostate maximum sectional area can predict clinically significant prostate cancer in PI-RADS 3 lesions at multiparametric magnetic resonance imaging
Upgrading an equivocal lesion in the peripheral zone (PI-RADS 3) to a... | Download Scientific Diagram
Frontiers | Sub-differentiation of PI-RADS 3 lesions in TZ by advanced diffusion-weighted imaging to aid the biopsy decision process
Frontiers | Sub-differentiation of PI-RADS 3 lesions in TZ by advanced diffusion-weighted imaging to aid the biopsy decision process